EcoDrugPlus

Monoamine Oxidase B

Ensembl ID : ENSTBEG00000000633
Gene Symbol: MAOB
1 Cross references
329 Possible Orthologues:

Monoglyceride Lipase

Ensembl ID : ENSTBEG00000012689
Gene Symbol: MGLL
1 Cross references
208 Possible Orthologues:

Myeloperoxidase

Ensembl ID : ENSTBEG00000013354
Gene Symbol: MPO
1 Cross references
181 Possible Orthologues:

Natriuretic Peptide Receptor 1

Ensembl ID : ENSTBEG00000015567
Gene Symbol: NPR1
1 Cross references
184 Possible Orthologues:

Natriuretic Peptide Receptor 2

Ensembl ID : ENSTBEG00000012526
Gene Symbol: NPR2
1 Cross references
259 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSTBEG00000004135
Gene Symbol: NPR3
1 Cross references
211 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSTBEG00000007167
Gene Symbol: NPY2R
1 Cross references
246 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 1

Ensembl ID : ENSTBEG00000003441
Gene Symbol: NTRK1
1 Cross references
199 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSTBEG00000007694
Gene Symbol: NTRK2
1 Cross references
286 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSTBEG00000008292
Gene Symbol: NTRK3
1 Cross references
269 Possible Orthologues:

Nicastrin

Ensembl ID : ENSTBEG00000000584
Gene Symbol: NCSTN
1 Cross references
203 Possible Orthologues:

Nischarin

Ensembl ID : ENSTBEG00000016716
Gene Symbol: NISCH
1 Cross references
209 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).